Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in ...

At 12 months, mean eGFR was 51.5 mL/min/1.73m2 in the imlifidase arm versus 19.3 mL/min/1.73m2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min/1 ...

Chronic liver disease (CLD) is prevalent worldwide, but clinicians often struggle to identify the precise aetiology. Renal involvement in CLD is also puzzling, with varied pathologies and risk factors ...

Baystreet.ca News Commentary – America's chronic disease burden has reached $4.9 trillion in annual healthcare expenditures, ...

In June 2024, Nkarta announced the initiation of Ntrust-I, a multi-center clinical trial of NKX019 in lupus nephritis, with ...

Using the PREVENT-CVD equation to guide management of high blood pressure could improve outcomes by identifying individuals ...

Detailed price information for Maze Therapeutics Inc (MAZE-Q) from The Globe and Mail including charting and trades.

Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing ...

Electric Drive Evolution: Sixth Generation eDrive Technology, Efficiency and Range Fully Enhanced ...

Once-daily oral GLP-1 drug orforglipron leads to significant, dose-dependent weight loss and metabolic benefits without diabetes.

MarketNewsUpdates News Commentary NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy ...

Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...